{"name":"Tenax Therapeutics","slug":"tenax","ticker":"TENX","exchange":"NASDAQ","domain":"tenaxthera.com","description":"Tenax Therapeutics is a specialty pharmaceutical company focused on cardiopulmonary diseases. The company's key products include rilapladib, a Phase 3 clinical-stage drug for treating pulmonary arterial hypertension (PAH). Tenax Therapeutics is positioned to capitalize on the growing demand for PAH treatments.","hq":"Morrisville, NC","founded":2008,"employees":"","ceo":"Anthony DiTonno","sector":"Cardiopulmonary / Specialty Pharma","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"0","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":32672000,"netIncome":-52599000,"cash":97600000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2016"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oxycyte","genericName":"Oxycyte","slug":"oxycyte","indication":"Other","status":"discontinued"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TNX-103","genericName":"TNX-103","slug":"tnx-103","indication":"Heart failure with preserved ejection fraction (HFpEF)","status":"phase_3"}]}],"pipeline":[{"name":"Oxycyte","genericName":"Oxycyte","slug":"oxycyte","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"TNX-103","genericName":"TNX-103","slug":"tnx-103","phase":"phase_3","mechanism":"TNX-103 is a cardiac myosin inhibitor that reduces the force of heart muscle contraction to improve cardiac function in heart failure patients.","indications":["Heart failure with preserved ejection fraction (HFpEF)"],"catalyst":""}],"recentEvents":[{"date":"2024-02-14","type":"regulatory","headline":"Tenax Therapeutics Announces FDA Acceptance of Rilapladib NDA","summary":"The FDA has accepted the New Drug Application (NDA) for rilapladib, a treatment for pulmonary arterial hypertension (PAH).","drugName":"rilapladib","sentiment":"positive"},{"date":"2023-11-14","type":"earnings","headline":"Tenax Therapeutics Reports Third Quarter 2023 Financial Results","summary":"Tenax Therapeutics reported its third-quarter 2023 financial results, with a net loss of $3.3 million.","drugName":"","sentiment":"neutral"}],"realNews":[{"date":"2026-03-10","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxObHdfNHlZUkZFZWRRUm9kalhlNFNXSm10ZTBEakZsQ0ZJVElRWWxWQmJSbmxYbnpYTG5FT0FwMkJVOERURWsxOGNONld6VHZINldwTElCa2RteE5kTERxeXgzMEd0eFBYQkw1UU1RSVhFcGwzWURCeE1ITkx0Qm1RTkNMS3ZDVl93U3ZMTnJtdlNPMi1fXzJkcTE1RGtnd1JxUENhejhMYzliMWJfY21pRE5fZGF2YjV5amptX3FnWVBlb2FYQ0llV2RXRkpWYzA1bHdDRHozRnl3SElnRmtFX1YycVVHZ0Z3cWVUSVB6UG93dGlDcUJUM9IB_gFBVV95cUxQQ1lSdnZwXzhkRnlFazJSU2NnRjR2VmtLUzFiT29oVW5QZUlmTjVhUGticHhXQjRWdFQyQi1SdVVTY0EwWUY0dDdnNUVjVDBPSmtoN0NMTWlMRHRlZF8zcHpoUGttT1NqVVFRWjc1N1hhdVJBZ2EwSTltcXZlWTdXODFsSGR4VzBIUzhJak1tWWsyc0M5VGFlLUVsWC12a2ZFb0hhWGYtck1xOXFhNVM3bF9fV3ZodC1UblhnQU1LcVV5WkxHTmUyUlRyT1AxUWR6Z0hmelM4Nno3NUg0MlBqcUUxd3FteVNobF9Fd3FRMXdMR2pzQ0lnYlhIUmZrUQ?oc=5","date":"2026-03-03","type":"deal","source":"The Manila Times","summary":"Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference - The Manila Times","headline":"Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxQTEpBR3hidENJQVJPcmRyZWtRa0haQ213SGZ1dU42SExzSy1DLUZtcy1tMDJ2eXFWYm9tVk1FN04xUV9TRXUtU3lEWmhlNHRxbElKb2dIQ3FsSUU0dXhySlNiR1l6WmlVcmhuTjN5ZVI5SzBsV1Fmd1U1MkViX24tdHV5YldRY2pzNkl3YnJHYTg0aTJpS3B6M3g3WWJ4Z3hGSkhjckU3TkpNTzg3cl9XeW55dm56bjJnLVJUaVVMYmloUDBuY3VBcWJ5SU1HQWVBTk8yTW02YkZNLUNPNmtWUl9vaEFCSG_SAewBQVVfeXFMTTR5OFprb2xoQlJiSjBEa25wLTdndkVxVXc3cGJLWmxDZHdqaGFHVjlZalluZnk0bzZ4ODJoS2hEdUtKeHlndzR3cHB0ejlvUDhJZUdLU29tRm93X2c3OXo2ZDctYi1jQWc3TE1QVTNwd1JpT1ZhdlNOM2R4NWltd2xJalYzTDQtV2c5QkE1T3JiM3RFZTg2MVJQWjlxNl9YU0RXWmxhbHdWUnhGbFRjWjhlRGpQUk5MWTZFejBVbkdSV0lZM2ZrTW1SODdnUmhCQ0Vwdkp2dXVFNU5ueGVwTG52NmVmWGpWYW5kczA?oc=5","date":"2026-01-10","type":"pipeline","source":"simplywall.st","summary":"Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans - simplywall.st","headline":"Tenax Therapeutics (NASDAQ:TENX) Is In A Good Position To Deliver On Growth Plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxQc0h6RWMtQ25WNVVycjNaV09hejBBLWZwVWZwRkhTOGJ2aXl2ZGJXNTZ6TlNzM3M5d2RxX2Y1WEVzbDhFNFlzYVc0a3FnOE9BcXcxOWZhWjNBY2JDakJDYXNicUJ3OHFzd0VOSUtWdXl4YTZWWWw0aTgtVTlUeHZhSXdxY3k?oc=5","date":"2026-01-08","type":"pipeline","source":"Yahoo Finance","summary":"Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick - Yahoo Finance","headline":"Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQc041bWZJMUVKZUpNNEZfNXpFUEtNaWRNNk9CcDNPR1RuelVzT0ptYVhJTzE3RGJTdTdOTzhybkxQT0IwN203Tk5OZmhvLWRENnB4Sl9IU1M3YXprdldSb3pXRzZhQkJvUEdPM3VKNHM4a2kxRkswZkdtSXRpSnhKSkh4THBPWFdDQTEyLVlrUVpJMTk0NkVCV3NKQWZLMW9EV0pIcHdGS2ViSDBVU0llalBUUUlsbmZrbzVv?oc=5","date":"2026-01-05","type":"trial","source":"Seeking Alpha","summary":"Tenax Therapeutics: How Lower Variance In Phase 3 Has \"Loaded The Dice\" For An Asymmetric Repricing - Seeking Alpha","headline":"Tenax Therapeutics: How Lower Variance In Phase 3 Has \"Loaded The Dice\" For An Asymmetric Repricing","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOZ2FrZ2NuNFZUQkZFVmhPbDJMQUw1YmZ5Qkw5MWNMdmNBRFhnZEprdkNVZm5PZUtSOTJpY3NrcURyWHNQbERhTE1BaXBicEdwYmRmMERBS05PM3pkdWJ5dXFvZFphWWFySVZrUFI2Z1g3ZGU1bDJDY1E3bjNzeXN6dUhNTTR1NTZxT1JGWkIxWkk0VGlWVGE3RA?oc=5","date":"2025-12-17","type":"pipeline","source":"Yahoo Finance","summary":"Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment - Yahoo Finance","headline":"Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9EcWdsLWhwNUx4RzlVYnJvamNqaF9Od0FIOWZaQjhXdnFiU0RvQ1pwaUltVkMyVUFpWnNtcm9Zb3BVS21td3lHdUxOWGZmT0ZMZmEw?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"TENX Stock Price, News & Analysis - Stock Titan","headline":"TENX Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgJBVV95cUxOT21UajMyTXh0OU1MSVFDUUM4ODhUTEZsZmlkY2hHUVFCX1RNWFJsMkE1MWFidzVacEcwTE5IQTlYbTR3WlRfZ1NKNk5CMXFEbC1rREtXNFF0S1p5QzgzWmtuYU9ndy1qcFRQbjBhbnRWQmVJaTE4R2FUOEltZFJib0RVOTdtbXV2bWJSdmU1czVRaXF0OXJBdnhrTEdwVmVNaXg3eTZSWWp2dDRJT2VKeGZvYXZmNHB0al9qVXRSa0dYZEJYeWRQVHM0Qkw5NnRTOE84TnBLT2dONW5GR0tSOEJ4NmhtN25LaldrSzNNdmtJbGNrdzR4YnNZMGxVZW9QbHprUVpR?oc=5","date":"2024-02-20","type":"deal","source":"GlobeNewswire","summary":"Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan - GlobeNewswire","headline":"Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE9jX2FfSGVMNmpfSDFCaVcxQ3R1UXB1VVJiWVpYQ09sWnJ1bDhDT3NsMExQT2dJTFh2Q01vc1FPQm94UmIyWmhrMzN6ZUVGdnJf?oc=5","date":"2024-01-03","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQUHpUSXkwcHVvR09iNWlyZG5KSWw3R0RqclRWUWMyRjUzdkJ3dGNaLVJwMnY2LTBaSzQtbUhMaU85Q09obDlCc3JKdzlWTy0wUDlHRnhKSDBoa1JtSVpwVERGelg3Tkc2b042WWk1NktXZEE5QUJ3NFJLc29DRndGamQ4MThYcXVCNVo0RQ?oc=5","date":"2023-11-13","type":"pipeline","source":"InvestorPlace","summary":"Why Is Tenax Therapeutics (TENX) Stock Up 300% Today? - InvestorPlace","headline":"Why Is Tenax Therapeutics (TENX) Stock Up 300% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE5McWEyay12TFZkZ0ljRW5IV1cwOTN3a3dwQ0gtWGVTQ1FBSFVoY21tNHJ1ZXFDSTVUMkJuRERRcGF2UzBkLXdqYXdkVk1qQmhsM0RaQTNtSFhKN3M3?oc=5","date":"2017-07-20","type":"pipeline","source":"TradingView","summary":"TENX Stock Price and Chart — NASDAQ:TENX - TradingView","headline":"TENX Stock Price and Chart — NASDAQ:TENX","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"discontinued":1,"phase_3":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["United Therapeutics","Bayer AG","Gilead Sciences"],"therapeuticFocus":["Cardiopulmonary","Specialty Pharma"],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2016-12-31","revenueHistory":[{"value":0,"period":"2016-12-31"},{"value":0,"period":"2015-12-31"},{"value":49286,"period":"2015-04-30"},{"value":158926,"period":"2014-04-30"},{"value":1666229,"period":"2013-04-30"},{"value":475301,"period":"2012-04-30"}],"grossProfit":0,"grossProfitHistory":[],"rdSpend":32672000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-52599000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":97600000,"cashHistory":[],"totalAssets":104227000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}